Cupps Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$133K Sell
4,414
-28,556
-87% -$862K 0.06% 141
2016
Q2
$902K Sell
32,970
-9,650
-23% -$247K 0.23% 129
2016
Q1
$1.14M Buy
+42,620
New +$1.04M 0.22% 121
2015
Q2
Sell
-208,376
Closed -$6.33M 211
2015
Q1
$6.33M Buy
208,376
+53,558
+35% +$1.39M 0.56% 69
2014
Q4
$3.06M Sell
154,818
-11,890
-7% -$266K 0.27% 96
2014
Q3
$3.32M Sell
166,708
-46,491
-22% -$978K 0.31% 105
2014
Q2
$4.86M Buy
+213,199
New +$3.8M 0.39% 89

Other funds holding RGEN

Cupps Capital Management's RGEN Position: Q3 2016 in Review

Cupps Capital Management reduced its Repligen (RGEN) stake by 87% in Q3 2016, selling an estimated $862K and leaving 4,414 shares worth $133K. The position accounts for 0.06% of the portfolio, ranked #141.

Cupps Capital Management first reported a position in RGEN in Q2 2014 and has held it in 7 quarters since. The position peaked at $6.33M in Q1 2015. 182 funds tracked by Wall St. Rank hold RGEN as of Q3 2016.

  • Cupps Capital Management held 4,414 shares of Repligen worth $133K as of Q3 2016.
  • Cupps Capital Management sold 28,556 Repligen shares in Q3 2016, an estimated $862K.
  • Repligen made up 0.06% of Cupps Capital Management's portfolio in Q3 2016, its #141 holding.
  • Cupps Capital Management first reported a position in Repligen in Q2 2014 and has held it in 7 quarters since.
  • Cupps Capital Management's Repligen position peaked at $6.33M in Q1 2015.
  • 182 funds tracked by Wall St. Rank held Repligen as of Q3 2016.

Based on Cupps Capital Management's 13F filing for Q3 2016, filed 11 Oct 2016.